On January 3, Lu Daopei Medical, a private medical specialist group that has been deeply involved in the domestic blood disease market for 21 years, submitted a form to the Hong Kong Stock Exchange. Lu Daopei Medical is a typical example of “academicians running medicine”. The soul is Lu Daopei, the founder of Chinese hematopoietic stem cell transplantation and academician of the Chinese Academy of Engineering. In this specialized field, Lu Daopei is the first company to be listed on the market, and also one of the few oncology medical companies to be listed in recent years. Before the IPO, CBC Group entity held 16.44%, Xiamen C&D entity held 11.27%, LDP New Hope held 10%, Temasek held 8.21% through Temasek SPV, and Yueyin Capital entity held 5.94%. | Related reading (Hexun.com)
This article is reproduced from: https://www.fortunechina.com/jingxuan/25824.htm
This site is only for collection, and the copyright belongs to the original author.